House Bill 5497
116th Congress(2019-2020)
Conditional Approval Act
Introduced
Introduced in House on Dec 19, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
5497
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Conditional Approval Act
This bill authorizes the Food and Drug Administration to conditionally approve certain new drugs intended for diseases that are seriously debilitating, life threatening, or chronic, and for which meaningful treatments do not exist. The bill also limits liability related to these conditionally approved drugs.December 19, 2019
12/20/2019
Referred to the Subcommittee on Health.
12/19/2019
Referred to the House Committee on Energy and Commerce.
12/19/2019
Introduced in House
Public Record
Record Updated
Oct 28, 2022 1:46:13 AM